FOX-04 DRI (Proxofim) — Research Peptide Overview, Specifications, and Sourcing
FOXO4-DRI is a D-retro-inverso peptide that selectively disrupts the FOXO4-p53 interaction in senescent cells, releasing p53 to trigger apoptosis exclusively in senescent cells. Research focuses on senolytic therapy and targeted senescent cell clearance.
FOXO4-DRI is a D-retro-inverso peptide that selectively disrupts the FOXO4-p53 interaction in senescent cells. By blocking this interaction, it releases p53 to trigger apoptosis exclusively in senescent cells while sparing healthy cells. Research focuses on senolytic therapy, age-related tissue dysfunction, and targeted clearance of senescent cell populations.
Wholesale FOX-04 DRI (Proxofim) Pricing
View FOX-04 DRI (Proxofim) Wholesale PricingAvailable FOX-04 DRI (Proxofim) Products
Ready to Order FOX-04 DRI (Proxofim)?
Get wholesale pricing, dedicated support, and fast fulfillment for your research needs.
Research Use Only (RUO).
Products sold by WholesaleBulkPeptides.com are intended solely for laboratory research, in-vitro testing,
and analytical reference purposes. These products are not intended for human or veterinary use, are not drugs,
food additives, or cosmetics, and may not be misbranded, misused, or mislabeled. These products have not been
tested or approved by the U.S. Food and Drug Administration (FDA) for any clinical or diagnostic purpose.
Purchasers assume full responsibility for compliance with all applicable local, state, and federal regulations.